Tempest Therapeutics' stock jumps nearly 4000% as liver-cancer treatment shows promise - MarketWatch
marketwatch.comSubmitted by marketwatch5869 in business
Oncology company’s board adopts poison-pill plan
Submitted by marketwatch5869 in business
Oncology company’s board adopts poison-pill plan